BRIANNA HENYECZ: Open Payments
NPI 1679227482 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$333 in 18 payments from 8 companies in 2025. Trend: 2023 $721 · 2024 $1,083 · 2025 $333
Food & beverage: $333
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $81 |
| PFIZER INC. | 4 | $69 |
| Janssen Biotech, Inc. | 3 | $61 |
| Alnylam Pharmaceuticals Inc. | 2 | $37 |
| Lilly USA, LLC | 2 | $36 |
| Philips North America LLC | 1 | $20 |
| Amgen Inc. | 1 | $16 |
| SOBI, INC | 1 | $14 |
Products named: LEQVIO, TREMFYA, ONPATTRO, MOUNJARO, VYNDAQEL, ELIQUIS, ECC Solutions, XELJANZ.
Industry payments across FL — which companies pay providers there.
